Valproic Acid
This medication is used to treat epilepsy (multiple seizure types), bipolar disorder (as a mood stabilizer), and to prevent migraines. It works by increasing the levels of the calming neurotransmitter GABA in the brain and by stabilizing electrical activity. It must never be taken during pregnancy due to a high risk of birth defects and developmental problems in the baby, and liver function and blood counts require regular monitoring.
Masse moléculaire
144,2110 g/mol
LogP
2,80
TPSA
37,30 Ų
Règle des 5 de Lipinski
Conforme
Aires thérapeutiques
Classes de médicaments
Mécanisme d'action
Enhances GABA transmission and blocks sodium/calcium channels.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Enhances GABA transmission and blocks sodium/calcium channels.
Structure 2D
Cite this structure
Embed this structure
SMILES
CCCC(CCC)C(=O)O
InChI
InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
Molecular Formula
C8H16O2
HBD / HBA
1 / 2
Liaisons Rotatives
5
Atomes Lourds
10
Valproic acid can displace warfarin from plasma protein binding sites and may inhibit platelet aggregation, increasing bleeding risk.
The combination of topiramate and valproic acid is associated with hyperammonemia and encephalopathy even without hepatotoxicity, representing a unique metabolic interaction.
Valproic acid doubles lamotrigine plasma concentrations by inhibiting its glucuronidation; the combination is associated with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gabapentin and valproic acid have a minor pharmacokinetic interaction; valproate may slightly increase gabapentin renal clearance.
Valproic acid displaces phenytoin from protein binding and inhibits its metabolism, leading to increased free phenytoin levels despite total levels that may appear unchanged or decreased.
Carbamazepine reduces valproic acid levels through enzyme induction, while valproic acid inhibits epoxide hydrolase, increasing the toxic carbamazepine-10,11-epoxide metabolite.
No side effects recorded
Side effect data is not yet available for this drug.
Foire aux questions
This medication is used to treat epilepsy (multiple seizure types), bipolar disorder (as a mood stabilizer), and to prevent migraines. It works by increasing the levels of the calming neurotransmitter GABA in the brain and by stabilizing electrical activity. It must never be taken during pregnancy due to a high risk of birth defects and developmental problems in the baby, and liver function and blood counts require regular monitoring.
Enhances GABA transmission and blocks sodium/calcium channels.
Key pharmacokinetic parameters for Valproic Acid: Half-life: 9-16 hours.
Yes, Valproic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
Related Drugs
Same Drug Class
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL109. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 3121. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="valproic-acid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/valproic-acid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/valproic-acid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/valproic-acid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="valproic-acid"></drugfyi-drug>